MapLight (MPLT) General Counsel Kristopher Hanson Sells 16,509 Shares

What Happened
Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), sold 16,509 shares on September 16, 2026. The filing reports a weighted-average sale price of $11.67 per share, for total proceeds of approximately $192,660. The sale was reported on a Form 4 filed September 18, 2026.

Key Details

• Transaction type: Sale (open market or private sale as reported).
• Transaction date: 2026-09-16; Form 4 filed: 2026-09-18 (appears timely).
• Price: weighted average $11.67; individual trade prices ranged from $11.38 to $12.17 (footnote F2).
• Proceeds: ≈ $192,660.
• Shares owned after transaction: Not stated in the provided filing excerpt.
• Notable footnotes:
  • F1: Sale was made pursuant to a Rule 10b5-1 trading plan adopted by Hanson on December 29, 2025.
  • F2: Weighted-average price reflects multiple trades; the filer will provide per-trade price breakdown on request.

Context
This was a planned sale under a pre-established 10b5-1 trading plan, which typically means the trades were scheduled in advance and should not be taken as an immediate signal of insider sentiment. Sales are common for routine liquidity or diversification; the filing provides no information on Hanson’s motivations. If you want the exact per-trade breakdown or post-transaction holdings, the filer can provide that information upon request per the footnote.